Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 4, 2024

https://www.globenewswire.com/news-release/2024/06/04/2893410/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

SOUTH SAN FRANCISCO, Calif., June 04, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that on May 31, 2024 it granted stock options to purchase an aggregate of 53,417 shares of common stock, 34,684 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting and 34,426 performance stock units (PSUs) that, if earned, will be settled in shares of common stock upon vesting to Sung H. Lee, the Company’s Executive Vice President and Chief Financial Officer, whose employment commenced on May 8, 2024, as a material inducement to his employment.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.